Advertisement

Topics

Locus Pharmaceuticals, Inc. Company Profile

18:08 EDT 23rd June 2018 | BioPortfolio

Locus Pharmaceuticals is a privately held pharmaceutical company focused on developing novel, small molecule therapeutic drugs to address major unmet medical needs. The foundation and competitiveness of Locus is based on the effective integration of our revolutionary computational technology with chemistry and biology expertise.

Location

4 Valley Square512 E. Township Line Road
Blue Bell
Pennsylvania
19422
United States of America

Contact

Phone: (215) 358-2000
Fax: (215) 358-2010
Email: locus-info@locuspharma.com


Drugs and Medications [275 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [372 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.

The advent of locus-specific protein recruitment technologies has enabled a new class of studies in chromatin biology. Epigenome editors enable biochemical modifications of chromatin at almost any spe...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Clinical Trials [270 Associated Clinical Trials listed on BioPortfolio]

Locus of Control and Spirituality in Palliative Care Patients

Primary Objectives: 1. To determine whether the degree of spirituality/religiosity as determined by the Duke University Religion Index and Functional Assessment of Chronic Illness ...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

LOC387715/HTRA1 Variants in Polypoidal Choroidal Vasculopathy in a Korean Population

This study is to investigate whether variants in the LOC387715 locus and the HtrA serine peptidase 1 (HTRA1) gene within the 10q26 locus are associated with polypoidal choroidal vasculopat...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1326 Associated Companies listed on BioPortfolio]

Locus Pharmaceuticals, Inc.

Locus Pharmaceuticals is a privately held pharmaceutical company focused on developing novel, small molecule therapeutic drugs to address major unmet medical needs. The foundation and competitiveness ...

Locus Discovery Incorporated

Locus Discovery Inc. is a privately held chemogenomics biopharmaceutical company organized in September 1999, and is based on technology exclusively licensed from the Sarnoff Corporation (SRI Internat...

Locus Genex Oy

Monoclonal Antibodies to Human Neurotransmitter Substances.manufacturer and supplier of monoclonals antibodies.

Ansaris

Ansaris is a division of Locus Pharmaceuticals, a privately held biopharmaceutical company focused on solving today’s small molecule drug discovery challenges, has been the l...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Locus Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Locus Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Locus Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Locus Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Locus Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Locus Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record